Alliance Foundation Trials Phase III PATINA Study Results Published in the New England Journal of Medicine
Addition of Palbociclib to Standard Maintenance Therapy Demonstrates Significant Progression-Free Survival Benefit in HR+, HER2+ Advanced Breast Cancer Alliance Foundation Trials, LLC (AFT) today announced the publication of the pivotal phase III PATINA study (AFT-38) in the New England Journal of Medicine (NEJM), marking a major milestone for patients with hormone receptor–positive (HR+), human epidermal…